1.440USD-2.70%Mkt Cap: 22.12M USDP/E: —Last update: 2026-06-01
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and CO…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap22.12M USD
Enterprise Value18.99M USD
Revenue (TTM)2.73M USD
Gross Profit2.73M USD
Net Income (TTM)9.17M USD
Revenue/Share0.2990 USD
Last Price1.440 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.36
PEG—
EV/EBITDA-0.97
EV/Revenue6.95
P/S8.09
P/B-21.16
EPS (TTM)-1.87
EPS (Forward)-4.03
52W Range
1.00019% of range3.270
52W High3.270 USD
52W Low1.000 USD
Profitability
Gross Margin100.00%
Oper. Margin-717.82%
EBITDA Margin0.00%
Profit Margin328.67%
ROE-1457.87%
ROA86.37%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.18M USD
CapEx (TTM)2.58M USD
FCF Margin-378.60%
FCF Yield-46.78%
Net Debt-3.13M USD
Net Debt/EBITDA0.16
Balance Sheet
Debt/Equity—
Current Ratio0.43
Quick Ratio0.36
Book Value/Sh-0.0690 USD
Cash/Share0.2070 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateSep 23, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)5.500 USD
Target Range3.000 USD – 8.000 USD
# Analysts2
Ownership
Shares Out.15.15M
Float11.73M
Insiders10.46%
Institutions29.79%
Short Interest
Short Ratio0.3d
Short % Float13.42%
Short % Out.11.03%
Shares Short1.67M
Short (prev mo.)405.60K
Technical
SMA 501.611 (-10.6%)
SMA 2001.887 (-23.7%)
Beta1.47
S&P 52W Chg27.70%
Avg Vol (30d)4.38M
Avg Vol (10d)854.73K
Technical Indicators
RSI (14)45.7
MACD-0.0146
MACD Signal0.0109
MACD Hist.-0.0255
BB Upper2.032 USD
BB Middle1.657 USD
BB Lower1.283 USD
BB Width45.18%
ATR (14)0.2235 USD
Vol Ratio (20d)0.04x